| 000 | 01733 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512022903.0 | ||
| 264 | 0 | _c19851119 | |
| 008 | 198511s 0 0 eng d | ||
| 022 | _a0263-6352 | ||
| 024 | 7 |
_a10.1097/00004872-198508000-00011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aCardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group. _h[electronic resource] |
| 260 |
_bJournal of hypertension _cAug 1985 |
||
| 300 |
_a379-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xchemically induced |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xchemically induced |
| 650 | 0 | 4 |
_aOxprenolol _xadverse effects |
| 650 | 0 | 4 | _aPulse |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSmoking |
| 650 | 0 | 4 |
_aSympatholytics _xtherapeutic use |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 773 | 0 |
_tJournal of hypertension _gvol. 3 _gno. 4 _gp. 379-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004872-198508000-00011 _zAvailable from publisher's website |
| 999 |
_c2870217 _d2870217 |
||